机构:
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USAOregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA
Lewinsohn, Deborah A.
[1
]
Gold, Marielle C.
论文数: 0引用数: 0
h-index: 0
机构:
Portland VA Med Ctr, Portland, OR USAOregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA
Gold, Marielle C.
[2
]
Lewinsohn, David M.
论文数: 0引用数: 0
h-index: 0
机构:
Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA
Portland VA Med Ctr, Portland, OR USAOregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA
Lewinsohn, David M.
[1
,2
]
机构:
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA
For many intracellular bacteria, both adaptively acquired and innately encoded effector T cells play a central role in the control, and in some cases, clearance of these pathogens. Through the rapid identification of those cells harboring intracellular bacteria, effector T cells have the capacity to both directly control the infection and shape the immune response to the pathogen. Here, we review the mechanisms by which effector T cells control intracellular infection and emphasize the means by which they recognize their targets. As will become evident, the diversity of both redundant and non-redundant effector mechanisms in conjunction with broad recognition of both protein and non-protein antigens allows for the identification of a broad array of bacterial pathogens and lessens the likelihood of immune evasion.